Possible Inhibitory Effect of Erythropoiesis-Stimulating Agents at the Predialysis Stage on Early-Phase Coronary Events after Hemodialysis Initiation

BACKGROUND: We examined whether the use of erythropoiesis-stimulating agents (ESAs) to correct anemia at the predialysis stage could inhibit early-phase coronary events after hemodialysis initiation. METHODS: We enrolled 242 patients with chronic kidney disease who had received continued medical tre...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cardiorenal Med
Autores principales: Nishimura, Masato, Watanabe, Keitaro, Kitamura, Yuki, Nagashima, Takao, Tokoro, Toshiko, Takatani, Toru, Sato, Nodoka, Yamazaki, Satoru, Hashimoto, Tetsuya, Kobayashi, Hiroyuki, Ono, Toshihiko
Formato: Artigo
Lenguaje:Inglês
Publicado: S. Karger AG 2016
Materias:
Original Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5159719/
https://ncbi.nlm.nih.gov/pubmed/27994599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000448009
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares